{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/50000744"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "PRESS RELEASEAcceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced it has been awarded a $1.5 million grant from the Muscular Dystrophy Association to support clinical studies of ACE-031 in Duchenne Muscular Dystrophy (DMD), a disabling neuromu" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "atvcapital.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/301662697"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/50000744" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/308723568"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/50000744"] } } }
